Patent · US Active

Citrate salt of an indole derivative and its pharmaceutical use

US8008294B2 · kind B2 · utility

0Cited by

1References

8Claims

0Family size

Assignee

ASTRAZENECA AB · SE

Inventors

Tesfai Sebhatu · Malung, SE
Erica Stahle · Malung, SE

Key dates

Filing date	Jan 31, 2007
Grant date	Aug 30, 2011
Priority date	—
Expiry date	Apr 14, 2028

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P43/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The salt, the 2-hydroxy-3-[5-(morpholin-4-ylmethyl)pyridin-2-yl]1H-indole-5-carbonitrile citrate, a process for its preparation, pharmaceutical formulations containing it and the use of it in therapy, and particularly in the therapy of GSK3 related conditions and disorders.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.